Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Intestinal Microbiota in Pediatric Surgical Cases Administered Bifidobacterium Breve: A Randomized Controlled Trial

  • 2016-07
  • Journal of Pediatric Gastroenterology and Nutrition 63(1)
    • T. Okazaki
    • T. Asahara
    • A. Yamataka
    • Yuki Ogasawara
    • Geoffrey J. Lane
    • K. Nomoto
    • S. Nagata
    • Y. Yamashiro

Study Design

Type
Randomized Controlled Trial (RCT)
Population
Pediatric surgical patients
Methods
Controlled experimental study

Abstract

The efficacy of perioperative probiotic administration has been reported in adults. We examined the effects of orally administered Bifidobacterium breve strain Yakult (BBG-01) on outcomes in pediatric surgical cases by assessing intestinal and blood microbiota. BBG-01 was well tolerated without adverse effects, and postoperative infectious complications were significantly decreased. Fecal analysis showed increased Bifidobacterium and decreased Enterobacteriaceae, Clostridium difficile, and Pseudomonas. Concentrations of fecal acetic acid were significantly increased, maintaining fecal pH at <7.0. The incidence of detecting bacteria in blood was significantly reduced. BBG-01 improved the intestinal environment, and may be implicated in suppressing bacterial translocation.

Research Insights

Back to top